'Antiplatelet agents' presentation slideshows

Medications for Secondary Prevention of Ischemic Stroke

Medications for Secondary Prevention of Ischemic Stroke. Alison Alleyne, PharmD David Thompson Health Region March 27, 2008. aalleyne@dthr.ab.ca. Outline. Pathophysiology of Ischemic Stroke (IS) Preventing IS ? preventing MI Antiplatelets Antithrombotics Statins ACEI & ARBS.

1.43k views • 64 slides

Medications for Secondary Prevention of Ischemic Stroke

Medications for Secondary Prevention of Ischemic Stroke. Alison Alleyne, PharmD David Thompson Health Region March 27, 2008. aalleyne@dthr.ab.ca. Outline. Pathophysiology of Ischemic Stroke (IS) Preventing IS ? preventing MI Antiplatelets Antithrombotics Statins ACEI & ARBS.

665 views • 64 slides

1.02k views • 47 slides

EBM demonstration

EBM demonstration. ??????? ???????. ???????. ???????? ???????? ????? ??????????? ?????????????????? ??. Clinical Problem. ?????????????????????. PICO. Patient: ???????? Intervention: ??????????? Comparison: ?????? Outcome: ?????. ???????. Patient Stroke patients

551 views • 38 slides

EBM demonstration

EBM demonstration. ??????? ???????. ???????. ???????? ???????? ????? ??????????? ?????????????????? ??. Clinical Problem. ?????????????????????. PICO. Patient: ???????? Intervention: ??????????? Comparison: ?????? Outcome: ?????. ???????. Patient Stroke patients

544 views • 38 slides

EBM demonstration

EBM demonstration. ??????? ???????. ???????. ???????? ???????? ????? ??????????? ?????????????????? ??. Clinical Problem. ?????????????????????. PICO. Patient: ???????? Intervention: ??????????? Comparison: ?????? Outcome: ?????. ???????. Patient Stroke patients

459 views • 38 slides

INTERHEART: Risk of Acute Myocardial Infarction associated with self-reported diabetes

Colhoun. HM et al. Lancet. 2004;364:685. -. 696. INTERHEART: Risk of Acute Myocardial Infarction associated with self-reported diabetes. Overall and Region-by-Region Odds ratio after adjusting for age, sex and smoking. Myocardial perfusion in diabetic patients.

636 views • 37 slides

Myocardial Infarction

Myocardial Infarction. By Dr. Hanan Said Ali. Learning Objectives. Define of myocardial infarction. Explain Pathophysiology of MI. Enumerate Clinical Manifestation of MI. Identify the diagnostic measures of MI. Discus complication of myocardial infarction.

1.93k views • 33 slides

Anticoagulation Therapy in the CICU: What, When, Why? Therese M. Giglia, MD December 14, 2014

307 views • 28 slides

543 views • 23 slides

CARDIOVASCULAR CARE of the OUTPATIENT

CARDIOVASCULAR CARE of the OUTPATIENT. Diane M. Enzweiler, MSN, ANP-BC St. Elizabeth Physicians: Heart and Vascular. Case Study.

267 views • 17 slides

Introduction

Introduction. Canadian Cardiovascular Society Antiplatelet Guidelines. Objectives.

288 views • 10 slides

Angina Pectoris Treatment Market Key Vendors, Trends and Forecasts upto 2021

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into Antiplatelet agents Beta-adrenergic blocking agents Calcium channel blockers Short & Long ? acting Nitroglycerines Angiotensin-converting enzyme (ACE) inhibitors Anti-ischemic agents Split by application, this report focuses on sales, market share and growth rate of Angina Pectoris Treatment in each application, can be divided into Hospitals Clinic Other.

147 views • 7 slides

Franchi, F. & Angiolillo, D. J. (2014) Novel antiplatelet agents in acute coronary syndrome

Table 1 Pharmacological properties of P2Y 12 -receptor inhibitors. Franchi, F. & Angiolillo, D. J. (2014) Novel antiplatelet agents in acute coronary syndrome Nat. Rev. Cardiol. doi:10.1038/nrcardio.2014.156.

170 views • 1 slides

Franchi, F. & Angiolillo, D. J. (2014) Novel antiplatelet agents in acute coronary syndrome

Table 3 Main differences between the TRITON-TIMI 38 and PLATO trial designs. Franchi, F. & Angiolillo, D. J. (2014) Novel antiplatelet agents in acute coronary syndrome Nat. Rev. Cardiol. doi:10.1038/nrcardio.2014.156.

256 views • 1 slides

Franchi, F. & Angiolillo, D. J. (2014) Novel antiplatelet agents in acute coronary syndrome

Figure 1 Mechanism of thrombus formation. Franchi, F. & Angiolillo, D. J. (2014) Novel antiplatelet agents in acute coronary syndrome Nat. Rev. Cardiol. doi:10.1038/nrcardio.2014.156.

231 views • 1 slides

Franchi, F. & Angiolillo, D. J. (2014) Novel antiplatelet agents in acute coronary syndrome

Table 4 Major ongoing phase III clinical trials of novel P2Y12-receptor inhibitors. Franchi, F. & Angiolillo, D. J. (2014) Novel antiplatelet agents in acute coronary syndrome Nat. Rev. Cardiol. doi:10.1038/nrcardio.2014.156.

260 views • 1 slides